FOCAL ONSET SEIZURES
Clinical trials for FOCAL ONSET SEIZURES explained in plain language.
Never miss a new study
Get alerted when new FOCAL ONSET SEIZURES trials appear
Sign up with your email to follow new studies for FOCAL ONSET SEIZURES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug tested for people whose epilepsy Won't respond to standard treatments
Disease control CompletedThis study tested an investigational drug called RAP-219 in 30 adults with focal epilepsy that does not respond well to current medications. The main goal was to see if RAP-219 safely reduces the frequency of seizures. Participants had a special implanted brain device that helped…
Matched conditions: FOCAL ONSET SEIZURES
Phase: PHASE2 • Sponsor: Rapport Therapeutics Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New epilepsy drug shows promise in reducing seizures
Disease control CompletedThis study tested whether adding a new drug called XEN1101 to existing medications could help reduce the frequency of focal seizures in adults with epilepsy. About 380 participants, who were already taking 1 to 3 seizure medications, received either XEN1101 or a placebo pill dail…
Matched conditions: FOCAL ONSET SEIZURES
Phase: PHASE3 • Sponsor: Xenon Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC